Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer

Table 2

Comparison of clinical efficacy between the two groups of patients.

Group	CR	PR	SD	PD	ORR (%)	DCR (%)
Treatment group	4	28	25	5	32 (51.6)	57 (91.9)
Control group	0	20	26	18	20 (31.3)	46 (71.9)
χ^2					5.39	8.49
					0.02	0.004